149 related articles for article (PubMed ID: 9104940)
1. Telomerase activity in ordinary meningiomas predicts poor outcome.
Langford LA; Piatyszek MA; Xu R; Schold SC; Wright WE; Shay JW
Hum Pathol; 1997 Apr; 28(4):416-20. PubMed ID: 9104940
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
3. Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
Chen HJ; Liang CL; Lu K; Lin JW; Cho CL
Cancer; 2000 Nov; 89(10):2092-8. PubMed ID: 11066050
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
Maes L; Kalala JP; Cornelissen R; de Ridder L
Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
[TBL] [Abstract][Full Text] [Related]
6. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
[TBL] [Abstract][Full Text] [Related]
7. Lack of alkaline phosphatase activity predicts meningioma recurrence.
Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
[TBL] [Abstract][Full Text] [Related]
8. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
[TBL] [Abstract][Full Text] [Related]
9. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical features and telomerase activity in human gliomas.
Huang F; Kanno H; Yamamoto I; Lin Y; Kubota Y
J Neurooncol; 1999 Jun; 43(2):137-42. PubMed ID: 10533725
[TBL] [Abstract][Full Text] [Related]
11. Telomerase in intracranial meningiomas.
Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Lupi G; Caniglia M; Pingitore R; Basolo F; Parenti G; Fontanini G
Int J Mol Med; 2003 Dec; 12(6):943-7. PubMed ID: 14612971
[TBL] [Abstract][Full Text] [Related]
12. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
[TBL] [Abstract][Full Text] [Related]
13. Differential telomerase expression and telomere length in primary intracranial tumors.
Chen HJ; Cho CL; Liang CL; Chen L; Chang HW; Lu K; Lee TC
Chang Gung Med J; 2001 Jun; 24(6):352-60. PubMed ID: 11512366
[TBL] [Abstract][Full Text] [Related]
14. The hTERT protein as a marker for malignancy in meningiomas.
Kalala JP; Maes L; Vandenbroecke C; de Ridder L
Oncol Rep; 2005 Feb; 13(2):273-7. PubMed ID: 15643510
[TBL] [Abstract][Full Text] [Related]
15. Management of Atypical and Anaplastic Meningiomas.
Buttrick S; Shah AH; Komotar RJ; Ivan ME
Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in 144 brain tumours.
Sano T; Asai A; Mishima K; Fujimaki T; Kirino T
Br J Cancer; 1998 May; 77(10):1633-7. PubMed ID: 9635839
[TBL] [Abstract][Full Text] [Related]
17. Atypical and malignant meningiomas: a clinicopathological review.
Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?
Strassner C; Buhl R; Mehdorn HM
Neurol Res; 2009 Jun; 31(5):478-82. PubMed ID: 19500450
[TBL] [Abstract][Full Text] [Related]
19. Benign versus atypical meningiomas: risk factors predicting recurrence.
Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
[TBL] [Abstract][Full Text] [Related]
20. Meningioma: an update.
Lusis E; Gutmann DH
Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
